Estimated cost-effectiveness of early screening strategies for newborn hearing impairment using a Markov model
Both the targeted screening and concurrent screening strategy exhibit good cost-effectiveness compared with only UNHS strategy. The targeted screening strategy is preferable when the willingness to pay is between $181.90/QALY and $1,563.45/QALY, whereas the concurrent screening strategy becomes the preferred choice when the willingness to pay exceeds $1,563.45/QALY.
Authors
- Beier Qi (ORCID: https://orcid.org/0000-0002-7172-7181)
- Hui En
- Jinge Xie
- Wen Cheng (ORCID: https://orcid.org/0000-0003-3975-0389)
- Lihui Huang
- Xiaohua Cheng
- Ruan Yu (ORCID: https://orcid.org/0009-0006-2128-1755)
- Gang Qin (ORCID: https://orcid.org/0000-0002-4363-2572)
- Demin Han
- Xiaomo Wang (ORCID: https://orcid.org/0009-0006-1159-3675)
- Jun-Tao Shu (ORCID: https://orcid.org/0009-0001-4959-1468)
Institutions
- Beijing Tongren Hospital (CN)
- Ministry of Education of the People's Republic of China (CN)
- Central South University (CN)
- Changsha Medical University (CN)
- Capital Medical University (CN)
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Beijing Institute of Neurosurgery (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fpubh.2025.1498860
- Citations
- 1
- Primary Topic
- Hearing, Cochlea, Tinnitus, Genetics
- Type
- article
- Field-Weighted Citation Impact
- 1.46
Funders
- National Natural Science Foundation of China